z-logo
open-access-imgOpen Access
HIV-1 decreases the levels of neurotrophins in human lymphocytes
Author(s) -
Valeriya Avdoshina,
Alfredo GarzinoDemo,
Alessia Bachis,
Maria CG Monaco,
Pauline M. Maki,
Rochelle E. Tractenberg,
Chenglong Liu,
Mary Young,
Italo Mocchetti
Publication year - 2011
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32834671b3
Subject(s) - neurotrophin , neurotrophic factors , brain derived neurotrophic factor , neurotrophin 3 , human immunodeficiency virus (hiv) , immunology , apoptosis , nerve growth factor , medicine , immunopathology , biology , psychology , receptor , genetics
Neurotrophins control cell survival. Therefore, we examined whether HIV-1 reduces neurotrophin levels. Serum of HIV-positive individuals exhibited lower concentrations of brain-derived neurotrophic factor (BDNF), but not of other neurotrophins, than HIV-negative individuals. In addition, R5 and X4 strains of HIV-1 decreased BDNF expression in T cells. Our results support the hypothesis that reduced levels of BDNF may be a risk factor for T-cell apoptosis and for neurological complications associated with HIV-1 infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom